Cargando…

Genetic Diagnosis and the Severity of Cardiovascular Phenotype in Patients With Elastin Arteriopathy

Elastin insufficiency causes recurrent vascular stenoses. Hemizygous deletion of the elastin gene (ELN) causes Williams-Beuren syndrome (WBS), while single nucleotide variants in ELN cause nonsyndromic supravalvar aortic stenosis (SVAS). Our objective was to compare cardiovascular disease outcomes i...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Sandar, Kinnear, Caroline, D’Alessandro, Lisa C.A., Bouwmeester, Jade, Yao, Roderick, Chiasson, David, Keeley, Fred, Mital, Seema
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748044/
https://www.ncbi.nlm.nih.gov/pubmed/32960096
http://dx.doi.org/10.1161/CIRCGEN.120.002971
_version_ 1783625041450106880
author Min, Sandar
Kinnear, Caroline
D’Alessandro, Lisa C.A.
Bouwmeester, Jade
Yao, Roderick
Chiasson, David
Keeley, Fred
Mital, Seema
author_facet Min, Sandar
Kinnear, Caroline
D’Alessandro, Lisa C.A.
Bouwmeester, Jade
Yao, Roderick
Chiasson, David
Keeley, Fred
Mital, Seema
author_sort Min, Sandar
collection PubMed
description Elastin insufficiency causes recurrent vascular stenoses. Hemizygous deletion of the elastin gene (ELN) causes Williams-Beuren syndrome (WBS), while single nucleotide variants in ELN cause nonsyndromic supravalvar aortic stenosis (SVAS). Our objective was to compare cardiovascular disease outcomes in patients with WBS and nonsyndromic SVAS. METHODS: Patients (81 WBS, 42 nonsyndromic SVAS) with cardiovascular disease were included in this retrospective single center study. Freedom from surgical and catheter interventions and reinterventions was compared. Vascular tissue from 8 patients and 6 controls was analyzed for arterial wall architecture. RESULTS: Patients with nonsyndromic SVAS presented at a younger age (median 0.3 [0.4–0.7] years) compared with patients with WBS (1.3 [0.2–3.0] years) and had lower freedom from surgical/catheter interventions compared with patients with WBS, with median event-free survival 1.1 (0.3–5.9) versus 4.7 (2.4–13.3) years, respectively (hazard ratio, 1.62 [95% CI, 1.02–2.56]; P=0.04). Patients with nonsyndromic SVAS also had a lower freedom from reinterventions (P=0.054 by log-rank test). This was related in part to a higher frequency of primary and reinterventions for concomitant valvar aortic stenosis. Histology revealed abnormal intimal and medial thickening, disorganized and fragmented elastic fibers, reduced smooth muscle calponin expression, and increased macrophage marker, CD68, expression in the arterial walls in patients with WBS and nonsyndromic SVAS compared with controls. CONCLUSIONS: Patients with nonsyndromic SVAS require early and more frequent vascular and valvular interventions and reinterventions, in particular for concomitant valvar aortic stenosis compared with patients with WBS. This provides important prognostic information to guide counseling of affected families with cardiovascular disease and may guide primary intervention strategies based on predicted risk of restenosis.
format Online
Article
Text
id pubmed-7748044
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-77480442020-12-22 Genetic Diagnosis and the Severity of Cardiovascular Phenotype in Patients With Elastin Arteriopathy Min, Sandar Kinnear, Caroline D’Alessandro, Lisa C.A. Bouwmeester, Jade Yao, Roderick Chiasson, David Keeley, Fred Mital, Seema Circ Genom Precis Med Original Articles Elastin insufficiency causes recurrent vascular stenoses. Hemizygous deletion of the elastin gene (ELN) causes Williams-Beuren syndrome (WBS), while single nucleotide variants in ELN cause nonsyndromic supravalvar aortic stenosis (SVAS). Our objective was to compare cardiovascular disease outcomes in patients with WBS and nonsyndromic SVAS. METHODS: Patients (81 WBS, 42 nonsyndromic SVAS) with cardiovascular disease were included in this retrospective single center study. Freedom from surgical and catheter interventions and reinterventions was compared. Vascular tissue from 8 patients and 6 controls was analyzed for arterial wall architecture. RESULTS: Patients with nonsyndromic SVAS presented at a younger age (median 0.3 [0.4–0.7] years) compared with patients with WBS (1.3 [0.2–3.0] years) and had lower freedom from surgical/catheter interventions compared with patients with WBS, with median event-free survival 1.1 (0.3–5.9) versus 4.7 (2.4–13.3) years, respectively (hazard ratio, 1.62 [95% CI, 1.02–2.56]; P=0.04). Patients with nonsyndromic SVAS also had a lower freedom from reinterventions (P=0.054 by log-rank test). This was related in part to a higher frequency of primary and reinterventions for concomitant valvar aortic stenosis. Histology revealed abnormal intimal and medial thickening, disorganized and fragmented elastic fibers, reduced smooth muscle calponin expression, and increased macrophage marker, CD68, expression in the arterial walls in patients with WBS and nonsyndromic SVAS compared with controls. CONCLUSIONS: Patients with nonsyndromic SVAS require early and more frequent vascular and valvular interventions and reinterventions, in particular for concomitant valvar aortic stenosis compared with patients with WBS. This provides important prognostic information to guide counseling of affected families with cardiovascular disease and may guide primary intervention strategies based on predicted risk of restenosis. Lippincott Williams & Wilkins 2020-09-22 /pmc/articles/PMC7748044/ /pubmed/32960096 http://dx.doi.org/10.1161/CIRCGEN.120.002971 Text en © 2020 The Authors. https://creativecommons.org/licenses/by-nc-nd/4.0/Circulation: Genomic and Precision Medicine is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made.
spellingShingle Original Articles
Min, Sandar
Kinnear, Caroline
D’Alessandro, Lisa C.A.
Bouwmeester, Jade
Yao, Roderick
Chiasson, David
Keeley, Fred
Mital, Seema
Genetic Diagnosis and the Severity of Cardiovascular Phenotype in Patients With Elastin Arteriopathy
title Genetic Diagnosis and the Severity of Cardiovascular Phenotype in Patients With Elastin Arteriopathy
title_full Genetic Diagnosis and the Severity of Cardiovascular Phenotype in Patients With Elastin Arteriopathy
title_fullStr Genetic Diagnosis and the Severity of Cardiovascular Phenotype in Patients With Elastin Arteriopathy
title_full_unstemmed Genetic Diagnosis and the Severity of Cardiovascular Phenotype in Patients With Elastin Arteriopathy
title_short Genetic Diagnosis and the Severity of Cardiovascular Phenotype in Patients With Elastin Arteriopathy
title_sort genetic diagnosis and the severity of cardiovascular phenotype in patients with elastin arteriopathy
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748044/
https://www.ncbi.nlm.nih.gov/pubmed/32960096
http://dx.doi.org/10.1161/CIRCGEN.120.002971
work_keys_str_mv AT minsandar geneticdiagnosisandtheseverityofcardiovascularphenotypeinpatientswithelastinarteriopathy
AT kinnearcaroline geneticdiagnosisandtheseverityofcardiovascularphenotypeinpatientswithelastinarteriopathy
AT dalessandrolisaca geneticdiagnosisandtheseverityofcardiovascularphenotypeinpatientswithelastinarteriopathy
AT bouwmeesterjade geneticdiagnosisandtheseverityofcardiovascularphenotypeinpatientswithelastinarteriopathy
AT yaoroderick geneticdiagnosisandtheseverityofcardiovascularphenotypeinpatientswithelastinarteriopathy
AT chiassondavid geneticdiagnosisandtheseverityofcardiovascularphenotypeinpatientswithelastinarteriopathy
AT keeleyfred geneticdiagnosisandtheseverityofcardiovascularphenotypeinpatientswithelastinarteriopathy
AT mitalseema geneticdiagnosisandtheseverityofcardiovascularphenotypeinpatientswithelastinarteriopathy